This gene seems to be silenced in breast cancer (38), ovarian cancer (39) and melanoma (9), suggesting that a specific methylation pattern of a group of genes, involving HOXD11, may be useful as diagnostic and prognostic biomarkers. The gene discussed is HOXD11; the disease is breast carcinoma.